Literature DB >> 33762897

The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Frances J Boly, Kimberly A Reske, Jennie H Kwon.   

Abstract

PURPOSE OF REVIEW: Accurate and timely diagnosis of Clostridioides difficile infection (CDI) is imperative to prevent C. difficile transmission and reduce morbidity and mortality due to CDI, but CDI laboratory diagnostics are complex. The purpose of this article is to review the role of laboratory tests in the diagnosis of CDI, and the role of diagnostic stewardship in optimization of C. difficile testing. RECENT
FINDINGS: Results from C. difficile diagnostic tests should be interpreted with an understanding of the strengths and limitations inherent in each testing approach. Use of highly sensitive molecular diagnostic tests without accounting for clinical signs and symptoms may lead to over-diagnosis of CDI and increased facility CDI rates. Current guidelines recommend a two-step, algorithmic approach for testing. Diagnostic stewardship interventions, such as education, order sets, order search menus, reflex orders, hard and soft stop alerts, electronic references, feedback and benchmarking, decision algorithms, and predictive analytics may help improve use of C. difficile laboratory tests and CDI diagnosis. The diagnostic stewardship approaches with the highest reported success rates include computerized clinical decision support (CCDS) interventions, face-to-face feedback, and real-time evaluations.
SUMMARY: CDI is a clinical diagnosis supported by laboratory findings. Together, clinical evaluation combined with diagnostic stewardship can optimize the accurate diagnosis of CDI.

Entities:  

Year:  2020        PMID: 33762897      PMCID: PMC7987129          DOI: 10.1007/s11908-020-0715-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  81 in total

1.  Use of whole-genome sequencing to guide a Clostridioides difficile diagnostic stewardship program.

Authors:  Kunal K Jakharia; Ghassan Ilaiwy; Siobhan S Moose; Masashi Waga; Lakshmi Appalla; Joel D McAlduff; Lynne V Karanfil; Patrick T McGann; Glenn W Wortmann
Journal:  Infect Control Hosp Epidemiol       Date:  2019-05-15       Impact factor: 3.254

2.  Effective utilization of C. difficile PCR and identification of clinicopathologic factors associated with conversion to a positive result in symptomatic patients.

Authors:  Mohamed E Mostafa; Timothy Flynn; Christopher P Hartley; Nathan A Ledeboer; Blake W Buchan
Journal:  Diagn Microbiol Infect Dis       Date:  2017-12-06       Impact factor: 2.803

3.  Lack of value of repeat stool testing for Clostridium difficile toxin.

Authors:  Sowjanya S Mohan; Brian P McDermott; Subha Parchuri; Burke A Cunha
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

4.  Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.

Authors:  J Origüen; L Corbella; M Á Orellana; M Fernández-Ruiz; F López-Medrano; R San Juan; M Lizasoain; T Ruiz-Merlo; A Morales-Cartagena; G Maestro; P Parra; J Villa; R Delgado; J M Aguado
Journal:  Clin Microbiol Infect       Date:  2017-08-12       Impact factor: 8.067

5.  Leveraging Quality Improvement Science to Reduce C. difficile Infections in a Community Hospital.

Authors:  Barbara B Lambl; Sarah Altamimi; Nathan E Kaufman; Mitchell S Rein; Monique Freeley; Maureen Duram; Wendy Krauss; Janice Kurowski; William E O'Neill; Paul Seeley; Mary Jo Gagnon; Duncan E Phillips; Marc S Rubin
Journal:  Jt Comm J Qual Patient Saf       Date:  2018-12-05

6.  Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

Authors:  Erik R Dubberke; Zhuolin Han; Linda Bobo; Tiffany Hink; Brenda Lawrence; Susan Copper; Joan Hoppe-Bauer; Carey-Ann D Burnham; William Michael Dunne
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

7.  Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing.

Authors:  Kathleen A Quan; Jennifer Yim; Doug Merrill; Usme Khusbu; Keith Madey; Linda Dickey; Amish A Dangodara; Scott E Rudkin; Margaret O'Brien; Daniel Thompson; Nimisha Parekh; C Gregory Albers; William C Wilson; Lauri Thrupp; Cassiana E Bittencourt; Susan S Huang; Shruti K Gohil
Journal:  Infect Control Hosp Epidemiol       Date:  2018-03-19       Impact factor: 3.254

8.  Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.

Authors:  Kerrie Eastwood; Patrick Else; André Charlett; Mark Wilcox
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

9.  Does my patient have Clostridium difficile infection?

Authors:  Lance R Peterson; Ari Robicsek
Journal:  Ann Intern Med       Date:  2009-08-04       Impact factor: 25.391

10.  Laxative use and testing for Clostridium difficile in hospitalized adults: An opportunity to improve diagnostic stewardship.

Authors:  Kayla A Carter; Anurag N Malani
Journal:  Am J Infect Control       Date:  2018-10-06       Impact factor: 2.918

View more
  3 in total

Review 1.  Diagnostic Stewardship in the Pediatric Intensive Care Unit.

Authors:  Anna C Sick-Samuels; Charlotte Woods-Hill
Journal:  Infect Dis Clin North Am       Date:  2022-03       Impact factor: 5.982

2.  Impact of Statewide Prevention and Reduction of Clostridioides difficile (SPARC), a Maryland public health-academic collaborative: an evaluation of a quality improvement intervention.

Authors:  Clare Rock; Rebecca Perlmutter; David Blythe; Jacqueline Bork; Kimberly Claeys; Sara E Cosgrove; Kate Dzintars; Valeria Fabre; Anthony D Harris; Emily Heil; Yea-Jen Hsu; Sara Keller; Lisa L Maragakis; Aaron M Milstone; Daniel J Morgan; Prashila Dullabh; Petry S Ubri; Christina Rotondo; Richard Brooks; Surbhi Leekha
Journal:  BMJ Qual Saf       Date:  2021-12-09       Impact factor: 7.035

3.  Clostridioides difficile Prevalence in the United States: National Inpatient Sample, 2016 to 2018.

Authors:  Molly R Petersen; Sara E Cosgrove; Eili Y Klein; Xianming Zhu; Thomas C Quinn; Eshan U Patel; M Kate Grabowski; Aaron A R Tobian
Journal:  Open Forum Infect Dis       Date:  2021-07-30       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.